Healthcare Edition / Coverage

Rowan Hale

Rowan Hale is the pen name used by Healthcare Edition’s founding editor. The publication focuses on health technology, policy and the delivery of care.

Editor

Health technology

Retatrutide versus Ozempic: what the 80-week trial compared

Lilly reports greater weight and blood-sugar changes in adults with type 2 diabetes. The comparator, hypothetical treatment conditions and unpublished full results define what can be concluded.

Policy & systems

HTI-5 changes EHR certification on more than one timetable

The US final rule removes 14 certification criteria and revises seven. Official tables separate the changes due at the effective date from later transitions and unfinished proposals.

Health technology

RadNet’s ONRAD deal is about who reads the scan

The proposed acquisition would add contracted radiologists and hospital staffing to RadNet’s imaging and software businesses. Those services play different roles in the reporting workflow.

Health technology

A small language model can label a radiology report without reading the scan

A single-centre study trained compact models to extract neck-fracture labels from written CT reports. Its results explain the difference between text extraction, image diagnosis and clinical deployment.

Policy & systems

Australia’s sunscreen reforms put the SPF evidence chain under scrutiny

The TGA plans changes to finished-product testing, laboratory oversight and ingredient quality. The October announcement begins further development rather than making every proposal a current requirement.

Home & community care

SWIFT dialysis trial: more conversations, no clear quality-of-life gain

The Australian SWIFT trial paired regular electronic questionnaires with feedback to patients and clinicians. Its conference results distinguish a change in care conversations from the main health outcome.

Policy & systems

What CDC’s new drug-resistance estimates actually count

The 2026 report estimates 9.7 million infections across its listed threats using mainly 2023 data. Changed methods, overlapping categories and C. difficile all matter when reading the total.

Health technology

Oncodetect’s new blood test looks for traces after cancer treatment

The tumour-informed test tracks DNA matched to a patient’s cancer. Its launch raises separate questions about detection limits, recurrence prediction and whether acting on a result improves care.

Health technology

Why an Ebola vaccine is being tested against Bundibugyo

The Tumaini trial has begun in DR Congo with Ervebo, a vaccine licensed for a different Ebola virus. The study is designed to establish evidence that existing approval cannot supply.